AgeX Therapeutics

AgeX Therapeutics is a U.S. biotechnology company focused on aging, age-related diseases, and regenerative medicine. Available information identifies Alameda, California, as the company’s headquarters and describes its work around an induced tissue regeneration (iTR) technology platform. The platform is intended to explore whether modulation of cellular states and regenerative mechanisms could help repair or restore damaged tissues. The available material is insufficient to verify specific clinical products, commercialization progress, corporate history, or current operating status, so no further claims are made about its candidates, development stages, or financial performance.

Available information describes AgeX Therapeutics as a biotechnology company focused on aging research and regenerative medicine, with operations identified in Alameda, California. Its stated technology focus is an induced tissue regeneration (iTR) platform involving concepts related to cellular reprogramming and tissue repair. Because verified public sources were not provided, the company’s founding date, founders, financing and M&A history, clinical-development milestones, and commercialization history cannot be reliably expanded here.

• Induced Tissue Regeneration platform

  A research platform used by AgeX Therapeutics to explore aging and tissue repair, with a focus on cellular-state modulation, cellular reprogramming, and related regenerative mechanisms. Available information does not establish specific drugs, clinical products, or commercial services associated with the platform.